GETI B logo

Getinge AB (publ) Stock Price

OM:GETI B Community·SEK 54.4b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 20 Fair Values set on narratives written by author

GETI B Share Price Performance

SEK 199.85
15.50 (8.41%)
SEK 224.70
Fair Value
SEK 199.85
15.50 (8.41%)
11.1% undervalued intrinsic discount
SEK 224.70
Fair Value
Price SEK 199.85
AnalystConsensusTarget SEK 224.70
AnalystHighTarget SEK 270.00
AnalystLowTarget SEK 169.66

GETI B Community Narratives

·
Fair Value SEK 224.7 11.1% undervalued intrinsic discount

Advanced Digital Health And Infection Control Will Drive Future Markets

0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
·
Fair Value SEK 270 26.0% undervalued intrinsic discount

Aging Populations, Digital Health And Emerging Markets Will Spur Lifesaving Demand

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
·
Fair Value SEK 169.66 17.8% overvalued intrinsic discount

Rising Tariffs And Regulation Will Squeeze Margins

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
SEK 169.66
17.8% overvalued intrinsic discount
Revenue
4.06% p.a.
Profit Margin
8.29%
Future PE
17.29x
Price in 2029
SEK 202.03
SEK 224.7
11.1% undervalued intrinsic discount
Revenue
4.56% p.a.
Profit Margin
9.39%
Future PE
19.96x
Price in 2029
SEK 268.33

Trending Discussion

Updated Narratives

GETI B logo

GETI B: Higher Dividend And Launch Of New EVH Platform Will Support Confidence

Fair Value: SEK 270 26.0% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
GETI B logo

GETI B: Dividend And Product Rollout Will Still Leave P/E Elevated

Fair Value: SEK 169.66 17.8% overvalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
GETI B logo

GETI B: Approved Dividend Will Support Future Returns Despite Slightly Lower Fair Value

Fair Value: SEK 224.7 11.1% undervalued intrinsic discount
8 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet, undervalued and pays a dividend.

1 Risk
4 Rewards

Getinge AB (publ) Key Details

SEK 34.1b

Revenue

SEK 17.9b

Cost of Revenue

SEK 16.2b

Gross Profit

SEK 13.8b

Other Expenses

SEK 2.4b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Jul 17, 2026
8.66
47.42%
6.92%
30.5%
View Full Analysis

About GETI B

Founded
1904
Employees
11754
CEO
Mattias Perjos
WebsiteView website
www.getinge.com

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments in Sweden and internationally. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers extracorporeal membrane oxygenation, mechanical ventilation, advanced patient monitoring, ICU infrastructure equipment, and drainage solutions. In addition, the company provides surgical perfusion, endoscopic vessel harvesting, intra-aortic balloon counterpulsation, vascular and cardiothoracic surgery equipment, peripheral stenting, OEM solutions, and beating heart surgery equipment; and operating room equipment, anesthesia, advanced patient monitoring, and operating room integration solutions. Further, it offers pre-cleaning, cleaning and disinfection, sterilization, consumables, endoscope reprocessing, and sterile supply management solutions; connected medical devices, and patient flow management; and low temperature sterilization, biocontainment in vaccine production, terminal sterilization, sterile isolation technology, cleaning and sterilization, aseptic transfer, and large-scale cultivation. Additionally, the company provides bioreactor preparation solution, bioprocess development and optimization, labware cleaning and sterilization, biocontainment, and vivarium. It offers its products through a network of sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia and Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.

Recent GETI B News & Updates

Narrative Update Jun 23

GETI B: Higher Dividend And Launch Of New EVH Platform Will Support Confidence

Analysts have maintained their SEK 270 price target for Getinge, citing updated assumptions for slightly lower discount rates, modestly higher revenue growth and profit margins, and supportive Street research, including an upgrade to Buy with a SEK 260 target. Together, these factors help underpin the current valuation view.
Narrative Update Jun 07

GETI B: Dividend And Product Rollout Will Still Leave P/E Elevated

Analysts have adjusted their price target on Getinge to SEK169.66 from SEK170.79. This reflects updated views on revenue growth, profit margins and a slightly higher assumed future P/E multiple.

Recent updates

No updates